SERPINB3 and cholangiocarcinoma: Despite the similarity in CCA classification and tumor size between the two groups, patients with high SerpinB3/4 scores (2+/3+) were more frequently classified as TNM stage III/IV (64.3% vs. 31.3%, p = 0.031).